AFC-HD AMS Life Science Co., Ltd.

2927

JP3124700000

Food Processing

Market Closed - Japan Exchange Other stock markets 07:00:00 07/06/2024 BST			5-day change	1st Jan Change
906 ^JPY	+1.12%		+2.72%	+13.25%

04-15	Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended February 2024, Payable on May 17, 2024	CI
2023	Afc-Hd Ams Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and Full Year Ending August 2024	CI

AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter of 2022, Payable on May 16, 2022

April 14, 2022 at 07:30 am

AFC-HD AMS Life Science Co., Ltd. announced a dividend of JPY 15 per share for the second quarter of 2022 against JPY 12.50 per share paid a year ago. This dividend is payable on May 16, 2022.

Latest news about AFC-HD AMS Life Science Co., Ltd.

Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended February 2024, Payable on May 17, 2024	04-15	CI
Afc-Hd Ams Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and Full Year Ending August 2024	13/10/23	CI
Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for Year Ended August 2023, Payable on November 29, 2023; Provides Dividend Guidance for Year Ending August 2024	13/10/23	CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire Clarize Co., Ltd. from Toshiaki Fujita for ¥1	01/10/23	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023	14/07/23	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023	14/07/23	CI
Tranche Update on AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback Plan announced on May 26, 2023.	27/06/23	CI
AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback announced on May 26, 2023, has closed with 100,000 shares, representing 0.71% for Â¥79.57 million.	26/06/23	CI
AFC-HD AMS Life Science Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million.	26/05/23	CI
AFC-HD AMS Life Science Co., Ltd. authorizes a Buyback Plan.	25/05/23	CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended Feb. 2023, Payable on May 29, 2023	14/04/23	CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Year Ending August 2023	14/04/23	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Year Ending August 2023	14/04/23	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2023	13/01/23	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023	13/01/23	CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire a 51% stake in 5SPRO Joint Stock Company.	11/12/22	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023	14/10/22	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Year End of Fiscal 2023	14/10/22	CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Year End August 2022, Payable on November 30, 2022	14/10/22	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending August 31, 2022	15/07/22	CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022	14/04/22	CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter of 2022, Payable on May 16, 2022	14/04/22	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Year End August 2022	14/04/22	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2022	14/01/22	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter of the Year Ending August 31, 2022	14/01/22	CI

Chart AFC-HD AMS Life Science Co., Ltd.

Duration

Period

More charts

AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.

Sector

Food Processing

Calendar

15/07/2024 - Q3 2024 Earnings Release

More about the company

	1st Jan change	Capi.
AFC-HD AMS LIFE SCIENCE CO., LTD.	+13.25%	80.84M
ZHEJIANG NHU COMPANY LTD.	+10.73%	7.96B
BELLRING BRANDS, INC.	+8.44%	7.66B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-0.58%	5.88B
THE SIMPLY GOOD FOODS COMPANY	-6.11%	3.72B
BYHEALTH CO., LTD	-13.21%	3.47B
XIAMEN KINGDOMWAY GROUP COMPANY	-15.49%	1.16B
HERBALIFE LTD.	-26.41%	1.12B
SIRIO PHARMA CO., LTD.	+9.98%	948M
USANA HEALTH SCIENCES, INC.	-11.42%	905M

Special Foods & Wellbeing Products